Fast Facts: Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Livre numérique |
| Taal: | Anglais |
| Gepubliceerd in: |
Basel :
S. Karger
2022.
Basel : |
| Online toegang: | https://www.karger.com/Book/Home/281591 Accès Université d'Orléans et IFPM |
| Opmerking: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Fast Facts: Chronic Lymphocytic Leukemia, 9783318069730 |
| LEADER | 02142nam a22002417a 4500 | ||
|---|---|---|---|
| 001 | 1326199 | ||
| 008 | 230215s2022 xx ||| |||| 00| 0 eng d | ||
| 009 | PPN267708653 | ||
| 020 | |a 9783318069747 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Eyre, Toby A. | |
| 245 | 1 | 0 | |a Fast Facts: Chronic Lymphocytic Leukemia |c Toby A. Eyre ; Parag Jasani, Lindsey E. Roeker. |
| 260 | |a Basel : |b S. Karger. | ||
| 260 | |a Basel : |b S. Karger, |c 2022. | ||
| 500 | |a Karger Fast Facts | ||
| 506 | |a Accès libre pour tout établissement ou utilisateur ayant un compte sur la plateforme de l'éditeur | ||
| 520 | |a Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally affects older adults and initially follows an indolent course, cytogenetic and molecular profiling have helped to predict clinical outcomes. Greater prognostication, alongside the development of an increasing armamentarium of novel targeted therapies, has enabled us to provide more personalized management options for patients.'Fast Facts: Chronic Lymphocytic Leukemia' covers the epidemiology, etiology, diagnosis and staging of the disease, and the molecular and genetic aspects that underpin treatment and prognosis. It provides a concise overview of treatment options, in both the front-line and relapsed/refractory settings, with particular focus on the novel targeted agents that have overcome many adverse prognostic factors, improving overall survival | ||
| 700 | 1 | |a Jasani, Parag. |4 aut | |
| 700 | 1 | |a Roeker, Lindsey E. |4 aut | |
| 776 | 0 | |t Fast Facts: Chronic Lymphocytic Leukemia |z 9783318069730 | |
| 856 | 4 | |u https://www.karger.com/Book/Home/281591 | |
| 856 | 4 | |5 452349901:858580985 |u https://ezproxy.univ-orleans.fr/login?url=https://www.karger.com/Book/Home/281591 |z Accès Université d'Orléans et IFPM | |
| 997 | |0 1326199 |1 Livre numérique |a Ressource numérique |b INSA |b ENSA |c 0/Bibliothèque numérique/ |c 1/Bibliothèque numérique/Autre ressource numérique/ | ||